leisure time -WSS

leisure time

author：leisure time 2025-08-26 07:42:31 - browse：68721

Allergan, Dom Smith/STAT

It wasn’t supposed to work out this way for Brent Saunders.

Four years ago, Saunders was the whiz kid of the pharmaceutical set. At 44, he had created a large pharmaceutical firm, then called Actavis, almost by force of will after engineering more than $100 billion in deals in a two-year span. Then he had swooped in to rescue Botox maker Allergan from the nefarious claws of Valeant Pharmaceuticals, an asset-stripping drug company loved by many on Wall Street but no one with a conscience.

As CEO, he paired his dealmaking with a boyish charm and a willingness to take on big issues that made him seem like a potential spokesman for the whole industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Russian special forces kill a gunman who broke into a private house near Moscow

focus

WSS

How artificial intelligence is being used to detect, treat cancer

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Trump got a 'target letter.' What is one and what does it mean?

Celebrate National Dole Whip Day for 3 days this week at Disney

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

knowledge

leisure time

hotspot

At least 13 dead in Texas as scorching temps continue

A double vaccine crisis is endangering millions of children

Tori Bowie and the unacceptable rates of Black maternal death

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

What does generative AI mean for health care? We asked experts

Body of missing toddler recovered in Delaware River days after flood: Police

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Norman Reedus' Daryl Dixon

Hollywood unions extend contract negotiations for actors

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

entertainment

India sets sights on home

Elizabeth Warren probes abortion access

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Researchers separate signal from noise in heart wearable data

White House launches permanent pandemic office

AbbVie dramatically boosts its spending on lobbying

focus

focus

entertainment

entertainment